Pfizer Retacrit [legacy through FY23] by Year

Name: Pfizer Retacrit [legacy through FY23] by Year (PFE)
Creator: Pfizer

Retacrit (epoetin alfa biosimilar) [legacy through FY23] — Worldwide revenues ($M) ($M)

Quarterly Annual

Pfizer Retacrit [legacy through FY23]: $80M in FY2023, up 1.3% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2023

Period ended Dec 31, 2023

Change on a year earlier

+1.3%

79 in FY2022

History

7 years

Since FY2017

Sources

Documents cited below

Where the FY2023 figure comes from

“|| Retacrit | 80 | 79 | 1% | (1%) | — | — | — | — | 1 | 3 | (43%) | (44%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗

Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Retacrit (epoetin alfa biosimilar) [legacy through FY23] — Worldwide revenues ($M) ($M)	Year on year	Source
FY2023	Dec 31, 2023	80	+1.3%	Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2022	Dec 31, 2022	79	-19.4%	Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2021	Dec 31, 2021	98	0.0%	Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2020	Dec 31, 2020	98	+18.1%	Form 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2019	Dec 31, 2019	83	+18.6%	Form 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2018	Dec 31, 2018	70	+4.5%	Form 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗
FY2017	Dec 31, 2017	67	–	Form 10-K (filed 2020-02-27) ↗

Breakdown

What makes up retacrit [legacy through FY23]

Cite this data

StockData. (2026). Pfizer Retacrit [legacy through FY23] ($M), annual FY2017–FY2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/retacrit-leg-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.